PP
BMY icon

Pingora Partners’s Bristol-Myers Squibb BMY Stock Holding History

Pingora Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Sell
33,855
-150
-0.4% -$8.74K 1.22% 16
2025
Q4 		$1.83M Buy
34,005
+7,825
+30% +$376K 1.12% 17
2025
Q3 		$1.18M Buy
26,180
+1,100
+4% +$51.4K 0.78% 28
2025
Q2 		$1.16M Buy
25,080
+2,270
+10% +$111K 0.87% 28
2025
Q1 		$1.39M Hold
22,810
– – 1.03% 24
2024
Q4 		$1.29M Buy
22,810
+576
+3% +$32.2K 0.85% 25
2024
Q3 		$1.15M Hold
22,234
– – 0.81% 25
2024
Q2 		$923K Sell
22,234
-800
-3% -$35.8K 0.65% 28
2024
Q1 		$1.25M Buy
23,034
+2,350
+11% +$120K 0.91% 25
2023
Q4 		$1.06M Buy
+20,684
New +$1.09M 0.94% 26

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pingora Partners's BMY Position: Q1 2026 in Review

Pingora Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.44% in Q1 2026, selling an estimated $8.74K and leaving 33,855 shares worth $2.05M. The position accounts for 1.22% of the portfolio, ranked #16.

Pingora Partners first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Pingora Partners held 33,855 shares of Bristol-Myers Squibb worth $2.05M as of Q1 2026.
  • Pingora Partners sold 150 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.74K.
  • Bristol-Myers Squibb made up 1.22% of Pingora Partners's portfolio in Q1 2026, its #16 holding.
  • Pingora Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.